HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kyriaki Mystakidou Selected Research

Fentanyl (Sublimaze)

1/2018Factors Affecting Opioid Treatment in Cancer Patients.
11/2013Breakthrough cancer pain: an observational study of 1000 European oncology patients.
7/2011Fentanyl nasal spray for the treatment of cancer pain.
7/2010Intranasal fentanyl: from pharmacokinetics and bioavailability to current treatment applications.
1/2007Oral transmucosal fentanyl citrate in cancer pain management: a practical application of nanotechnology.
9/2005Comparison of transdermal fentanyl with codeine/paracetamol, in combination with radiotherapy, for the management of metastatic bone pain.
5/2005Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: an overview of its pharmacological and clinical characteristics.
3/2005Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: an overview of its pharmacological and clinical characteristics.
3/2004Pain management of cancer patients with transdermal fentanyl: a study of 1828 step I, II, & III transfers.
3/2004Investigating the effects of TTS-fentanyl for cancer pain on the psychological status of patients naïve to strong opioids: an open label study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kyriaki Mystakidou Research Topics

Disease

72Neoplasms (Cancer)
02/2022 - 01/2002
33Pain (Aches)
09/2020 - 01/2002
15Neoplasm Metastasis (Metastasis)
07/2019 - 07/2003
10Cancer Pain
02/2022 - 01/2002
9Breakthrough Pain
11/2013 - 09/2004
5Breast Neoplasms (Breast Cancer)
01/2021 - 06/2004
3Nausea
01/2013 - 03/2002
3Chronic Pain
05/2011 - 09/2004
3Bone Diseases (Bone Disease)
12/2008 - 01/2005
2Fatigue
01/2019 - 10/2008
2Acute Pain
07/2010 - 03/2002
2Mucositis
10/2006 - 06/2005
2Vomiting
01/2004 - 03/2002
1Constipation
02/2022
1Opioid-Induced Constipation
02/2022
1Hematologic Neoplasms (Hematological Malignancy)
07/2020
1Head and Neck Neoplasms (Head and Neck Cancer)
01/2020
1Obesity
01/2018
1Opioid-Related Disorders (Opiate Addiction)
01/2016
1Primary Myelofibrosis (Myelosclerosis)
07/2015
1Splenomegaly
07/2015
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2015
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2015
1Lung Neoplasms (Lung Cancer)
01/2015
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2014
1Hepatocellular Carcinoma (Hepatoma)
01/2013
1Carcinoma (Carcinomatosis)
01/2013
1Thrombosis (Thrombus)
01/2013
1Central Sleep Apnea (Central Sleep Apnea Syndrome)
01/2012
1Hypercapnia
01/2012
1Sleep Apnea Syndromes (Sleep Apnea)
01/2012
1Hypoxia (Hypoxemia)
01/2012
1Liposarcoma
01/2011
1Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2011
1Colonic Neoplasms (Colon Cancer)
12/2008
1Uterine Hemorrhage (Uterine Bleeding)
09/2008
1Precocious Puberty
09/2008
1Neuroblastoma
11/2007
1Diarrhea
05/2006
1Anemia
09/2005
1Chronic Disease (Chronic Diseases)
09/2005
1Death (Near-Death Experience)
01/2005

Drug/Important Bio-Agent (IBA)

21Opioid Analgesics (Opioids)IBA
01/2018 - 01/2002
15Fentanyl (Sublimaze)FDA LinkGeneric
01/2018 - 01/2002
9Analgesics (Analgesic Drugs)IBA
01/2018 - 01/2002
54-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
04/2018 - 10/2004
5Diphosphonates (Bisphosphonates)IBA
01/2014 - 06/2004
4Zoledronic Acid (Zometa)FDA Link
01/2011 - 01/2005
4Morphine (MS Contin)FDA LinkGeneric
07/2010 - 01/2002
3Codeine (Codeine Phosphate)FDA LinkGeneric
09/2005 - 01/2004
2Pharmaceutical PreparationsIBA
10/2014 - 03/2002
2Amifostine (Ethyol)FDA LinkGeneric
10/2006 - 06/2005
2Octreotide (Sandostatin)FDA LinkGeneric
05/2006 - 03/2002
2Biomarkers (Surrogate Marker)IBA
01/2006 - 06/2004
2Acetaminophen (Paracetamol)FDA LinkGeneric
09/2005 - 01/2004
2Pamidronate (Aredia)FDA LinkGeneric
06/2004 - 07/2003
1naloxegolIBA
02/2022
1Heroin (Diamorphine)IBA
01/2016
1MagnesiumIBA
01/2015
1Phosphorus (Red Phosphorus)IBA
01/2015
1SamariumIBA
10/2014
1glycidyl trimethylammonium (G-MAC)IBA
11/2012
1Hypnotics and Sedatives (Sedatives)IBA
01/2012
1Nasal SpraysIBA
07/2011
1TabletsIBA
07/2011
1Delayed-Action PreparationsIBA
05/2011
1Opiate AlkaloidsIBA
07/2010
1Ibandronic Acid (Boniva)FDA Link
12/2008
1Hemoglobins (Hemoglobin)IBA
10/2008
1Estradiol (Delestrogen)FDA LinkGeneric
09/2008
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
11/2007
1ErythropoietinFDA Link
11/2007
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2007
1Indicators and Reagents (Reagents)IBA
01/2007
1Loperamide (Imodium)FDA LinkGeneric
05/2006
1collagen type I trimeric cross-linked peptideIBA
01/2006
1lipid-associated sialic acid (LASA)IBA
01/2006
1IronIBA
09/2005
1Epoetin Alfa (Epogen)FDA Link
09/2005
1Prostate-Specific Antigen (Semenogelase)IBA
01/2005
1Tumor Biomarkers (Tumor Markers)IBA
01/2005
1AndrogensIBA
01/2005

Therapy/Procedure

41Palliative Care (Palliative Therapy)
01/2021 - 04/2002
19Radiotherapy
01/2019 - 07/2003
6Drug Therapy (Chemotherapy)
07/2019 - 09/2005
4Therapeutics
01/2012 - 06/2005
4Euthanasia (Mercy Killing)
10/2010 - 01/2005
3Analgesia
01/2018 - 01/2004
3Assisted Suicide (Physician Assisted Suicide)
10/2010 - 08/2006
2Activities of Daily Living (ADL)
03/2013 - 01/2013
2Pain Management
09/2005 - 03/2004
1Complementary Therapies (Alternative Medicine)
09/2020
1Musculoskeletal Manipulations (Manipulative Therapy)
09/2020
1Hematopoietic Stem Cell Transplantation
07/2020
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2020
1Prophylactic Mastectomy
03/2015
1Intravenous Administration
10/2014
1Conformal Radiotherapy
01/2013
1Oral Administration
07/2011
1Chemoradiotherapy
01/2011